International Assets Investment Management LLC Makes New Investment in Semler Scientific Inc. $SMLR

Key Points

• International Assets Investment Management LLC recently acquired 12,700 shares of Semler Scientific Inc. for approximately $492,000, increasing its stake to 0.09% in the company.
• Semler Scientific reported a strong quarterly earnings result of $5.04 EPS, significantly beating the consensus estimate and achieving a net margin of 86.20%.
• Several analysts have revised their target prices for Semler Scientific, with a consensus rating of "Moderate Buy" and a target price of $74.25.

International Assets Investment Management LLC acquired a new position in shares of Semler Scientific Inc. (NASDAQ:SMLR - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 12,700 shares of the company's stock, valued at approximately $492,000. International Assets Investment Management LLC owned approximately 0.09% of Semler Scientific as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Interchange Capital Partners LLC purchased a new position in Semler Scientific during the 1st quarter worth approximately $46,502,000. Charles Schwab Investment Management Inc. grew its position in Semler Scientific by 226.1% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 158,576 shares of the company's stock worth $5,740,000 after purchasing an additional 109,951 shares in the last quarter. Deltec Asset Management LLC grew its position in Semler Scientific by 112.0% during the 2nd quarter. Deltec Asset Management LLC now owns 100,932 shares of the company's stock worth $3,910,000 after purchasing an additional 53,332 shares in the last quarter. Generali Asset Management SPA SGR purchased a new position in Semler Scientific during the 2nd quarter worth approximately $2,712,000. Finally, Pacer Advisors Inc. purchased a new position in Semler Scientific during the 1st quarter worth approximately $1,874,000. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Semler Scientific Stock Down 0.6%

SMLR stock opened at $23.51 on Wednesday. The company has a current ratio of 0.60, a quick ratio of 0.58 and a debt-to-equity ratio of 0.25. Semler Scientific Inc. has a 1 year low of $22.59 and a 1 year high of $81.56. The company has a fifty day simple moving average of $29.33 and a 200 day simple moving average of $34.18. The firm has a market cap of $355.94 million, a PE ratio of 9.67 and a beta of 1.41.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The company reported $5.04 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $5.31. Semler Scientific had a net margin of 86.20% and a return on equity of 43.84%. The business had revenue of $8.22 million during the quarter, compared to analyst estimates of $8.10 million.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Maxim Group lowered their price objective on shares of Semler Scientific from $95.00 to $80.00 and set a "buy" rating on the stock in a research report on Friday, September 19th. Cantor Fitzgerald decreased their target price on shares of Semler Scientific from $61.00 to $60.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Benchmark decreased their target price on shares of Semler Scientific from $101.00 to $86.00 and set a "buy" rating for the company in a research note on Tuesday, September 23rd. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Semler Scientific in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $74.25.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.